about
Assessments of the importance of provider characteristics for abortion care: data from women in Rajasthan, India.Characteristics and outcomes among older HIV-positive adults enrolled in HIV programs in four sub-Saharan African countriesLow risk of attrition among adults on antiretroviral therapy in the Rwandan national program: a retrospective cohort analysis of 6, 12, and 18 month outcomesFactors associated with late antiretroviral therapy initiation among adults in MozambiqueA combination strategy for enhancing linkage to and retention in HIV care among adults newly diagnosed with HIV in Mozambique: study protocol for a site-randomized implementation science study.High levels of adherence and viral suppression in a nationally representative sample of HIV-infected adults on antiretroviral therapy for 6, 12 and 18 months in Rwanda.Advanced disease at enrollment in HIV care in four sub-Saharan African countries: change from 2006 to 2011 and multilevel predictors in 2011.Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.High attrition before and after ART initiation among youth (15-24 years of age) enrolled in HIV careUntangling the Relationship Between Antiretroviral Therapy Use and Incident Pregnancy: A Marginal Structural Model Analysis Using Data From 47,313 HIV-Positive Women in East Africa.Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries.Patients enrolled in HIV care in Mozambique: baseline characteristics and follow-up outcomes.Attrition From Human Immunodeficiency Virus Treatment Programs in Africa: A Longitudinal Ecological Analysis Using Data From 307 144 Patients Initiating Antiretroviral Therapy Between 2005 and 2010.Pregnancy desire and dual method contraceptive use among people living with HIV attending clinical care in Kenya, Namibia and TanzaniaIdentifying Perceived Barriers along the HIV Care Continuum: Findings from Providers, Peer Educators, and Observations of Provider-Patient Interactions in Ethiopia.HIV Care and Treatment Beliefs among Patients Initiating Antiretroviral Treatment (ART) in Oromia, EthiopiaFactors associated with initiation of antiretroviral therapy in the advanced stages of HIV infection in six Ethiopian HIV clinics, 2012 to 2013The problem of late ART initiation in Sub-Saharan Africa: a transient aspect of scale-up or a long-term phenomenon?Factors associated with loss to clinic among HIV patients not yet known to be eligible for antiretroviral therapy (ART) in MozambiqueUse of a Comprehensive HIV Care Cascade for Evaluating HIV Program Performance: Findings From 4 Sub-Saharan African Countries.Decentralization of HIV care and treatment services in Central Province, Kenya.Monitoring quality at scale: implementing quality assurance in a diverse, multicountry HIV program.TB diagnostic capacity in sub-Saharan African HIV care settings.Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-saharan African countries.Feasibility and Acceptability of Health Communication Interventions Within a Combination Intervention Strategy for Improving Linkage and Retention in HIV Care in Mozambique.Strategies for more effective monitoring and evaluation systems in HIV programmatic scale-up in resource-limited settings: Implications for health systems strengthening.Availability of nutritional support services in HIV care and treatment sites in sub-Saharan African countries.PEPFAR programs linked to more deliveries in health facilities by African women who are not infected with HIV.Stigma And HIV Care Continuum Outcomes Among Ethiopian Adults Initiating ART.Implementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012.Determinants of nonadherence to a single-dose nevirapine regimen for the prevention of mother-to-child HIV transmission in Rwanda.Informing efforts to reach UNAIDS' 90-90-90 targets: a comparison of characteristics of people diagnosed with HIV in health facilities to the general population of people living with HIV in Mozambique.Mifepristone-misoprostol abortion: a trial in rural and urban Maharashtra, India.Psychological distress, health and treatment-related factors among individuals initiating ART in Oromia, Ethiopia.Disclosure History Among Persons Initiating Antiretroviral Treatment at Six HIV Clinics in Oromia, Ethiopia, 2012-2013.Household decision-making power and the mental health and well-being of women initiating antiretroviral treatment in Oromia, Ethiopia.Rejoinder to "Lost Opportunities Concerning Loss-to-Follow-Up: A Response to Elul et al." by Strassle and colleagues.Sex Differences in Mortality and Loss Among 21,461 Older Adults on Antiretroviral Therapy in Sub-Saharan Africa.Gender Differences and Psychosocial Factors Associated with Quality of Life Among ART Initiators in Oromia, Ethiopia.Advanced Human Immunodeficiency Virus Disease at Diagnosis in Mozambique and Swaziland.
P50
Q33770724-7A3B6700-322B-49B2-B09A-CAC37C6B6919Q33975574-62594BEB-9294-4D34-8770-F35A5C101D40Q34169040-E807152B-63CB-442B-AB1F-7568744B6547Q34277766-43624C00-FF98-47EE-9D57-469E8A4F3E66Q34410468-29B434D9-0140-4ED1-BA9C-8E677D5E460DQ34551552-F8B9E2DE-7B8B-4C88-AC65-F690CFA042E4Q35180760-DD0996A5-39C4-4323-B771-6B3D37442753Q35477959-D5FD2E34-5790-4ACE-8052-BFB48EB3EDFEQ35896189-A14ADBE3-29DF-44DA-9372-4E0249D80A2EQ35934094-AD09220F-6BE6-44A8-AFF5-B45F526A8033Q36175269-F30AF32A-304D-415C-B8B9-FDF001892BCDQ36175342-E628048B-F174-4CBC-A870-E495585D438FQ36318628-D878D40B-D19C-4BD4-B881-D0E60179FDC7Q36331514-71DE706A-A9A7-4849-B360-025D899996CEQ36464031-B8CA3DB7-1696-4BCB-8E93-FDE820DB21ADQ36660572-8E979C24-E860-4D21-9FE2-ADF2048C4748Q36837250-1C8E3DC5-0D69-4850-B002-A24EF1C00614Q36848380-E3A09209-88CD-4DA9-A8DD-47DC6438E63CQ36920997-1022E0FA-1F5E-40DF-8F13-051827CF6CF3Q37391454-6CF33629-8E1C-4DFB-9648-872408704C4AQ37412441-F7DD12BF-2E04-45FB-B5B3-9DA3E7BFE372Q37445066-124BEB97-5CCA-463E-809A-8DF3BC13F062Q37472599-D3305D36-A0B2-4063-B59F-7C08CCF12FF2Q37473041-4613A03E-1EF9-4D29-8356-46D00BF7E8C7Q37488442-8B143506-BDAF-49D9-BA45-9B6BA34F8E40Q37621994-B5042D7D-62EE-44D6-81A0-7335E41E0F9EQ37685937-4A15512D-1CC7-4401-A933-41928E0CD141Q38415315-52F66D86-B5A5-4851-87D6-A72FF9D2C435Q38611529-76BB4FB7-F5A8-43BC-BA5F-6C25FB32CF3FQ38855709-CEE228B7-79AD-4785-BEC3-BA5F41EB2F1BQ38969615-E7F9CBD7-D0F6-4C7A-B864-CD1623C81379Q39040608-C4143571-FBC8-4B6B-9CE6-B243DB33781FQ39611166-EC2836EF-813F-4110-8E44-CE491E0AAC56Q40078510-45E0C6BA-AB9D-4920-9445-14498BEAFC9FQ40092509-3013293E-1FC8-4601-BE59-BEECC2FCED78Q40095943-CB27E40E-6DD1-4B3A-AC56-3902AFC0DF79Q40293777-452F513F-DC64-43DE-9041-F72E0A2F8096Q40580023-C43E620D-772C-4D54-9062-310FD8B48155Q40709335-38B5A2A4-54E5-47D0-BB96-43D1A11422B6Q41676901-9BE477F0-9FEA-4587-935D-06A97AD7E3C2
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Batya Elul
@ast
Batya Elul
@en
Batya Elul
@es
Batya Elul
@nl
type
label
Batya Elul
@ast
Batya Elul
@en
Batya Elul
@es
Batya Elul
@nl
prefLabel
Batya Elul
@ast
Batya Elul
@en
Batya Elul
@es
Batya Elul
@nl
P106
P31
P496
0000-0001-6101-3073